【can cbd oil expire】Morgan Stanley Downgrades Hologic On Tough Cynosure Recovery, Surgery Business Risks
Although
Hologic,can cbd oil expire Inc.
(NASDAQ:
HOLX
) acquired
Cynosure
to achieve a higher weighted average market growth rate, Cynosure's main businesses have not delivered as expected, according to Morgan Stanley.
The Analyst
Morgan Stanley’s David Lewis downgraded
Hologic
from
Equal-weight to Underweight
and cut the price target from $44 to $39.
The Thesis
Hologic diversified into aesthetics with its purchase of Cynosure, with expectations of generating higher WAMGR, Lewis said in the Wednesday downgrade note.
Yet MonaLisa Touch and SculpSure — which drove almost all of Cynosure’s growth prior to the acquisition — have not returned to their pre-acquisition levels, the analyst said.
The body sculpting channel is showing signs of saturation, and the company's women’s health strategy appears flawed given the FDA’s latest scrutiny of vaginal rejuvenation, Lewis said.
Competition for NovaSure will intensify if Channel Medsystem’s Cerene snags FDA approval in mid-2019, he said.
Hologic operates in slower growth end markets versus its peers and has a WAMGR of around 3.5 percent, which is significantly below that the competition's 5 percent, the analyst said.
“A structural 3-percent organic and 8-percent EPS growth profile is below peers at 5-6 percent organic and double-digit earnings growth, which suggests Hologic is likely to relatively underperform peers."
Price Action
Hologic shares were trading down 6.45 percent at $38.45 at the time of publication Wednesday.
Related Links:
Hologic Downgraded By BofA As Cynosure Headwinds Persist
Hologic: Meet Goldman Sach's New 'Conviction Buy'
Photo courtesy of Hologic.
Latest Ratings for HOLX
Jan 2019
Morgan Stanley
Downgrades
Equal-Weight
Underweight
Nov 2018
RBC Capital
Maintains
Sector Perform
Sector Perform
Oct 2018
Morgan Stanley
Maintains
Equal-Weight
Equal-Weight
View More Analyst Ratings for HOLX
View the Latest Analyst Ratings
See more from Benzinga
JPMorgan Sees Buying Opportunity In Torchmark
Analyst: NeuroMetrix Benefits From Alternative Pain Management Trend
Stemline's Elzonris Launch On Schedule, HC Wainwright Says In Bullish Initiation
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
View comments
下一篇:Fatalities on commercial passenger aircraft rise in '18
相关文章:
- Unibail-Rodamco-Westfield (“URW”) announces tender offer results
- PharmaCielo Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In PharmaCielo Ltd. To Contact The Firm
- Is Husqvarna AB (publ) (STO:HUSQ B) An Attractive Dividend Stock?
- FIRST FIRM TO INVESTIGATE NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Carnival Corporation & Plc and Encourages Investors with Losses of $100,000 to Contact the Firm
- Margaux Resources Announces Collaboration with GoldSpot Discoveries and Spring Work Program on Cassiar Gold Project
- Here's What World Precision Machinery Limited's (SGX:B49) P/E Is Telling Us
- Platinum Group Metals Ltd. Completes At-The-Market Offering
- SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Canaan Inc. and Encourages Investors with Losses to Contact the Firm
- Microsoft (MSFT) Is a Bargain Stock You Can Buy Today
- What Bloomberg's massive campaign spending would cost the average American
相关推荐:
- What Can We Learn About FRP Holdings' (NASDAQ:FRPH) CEO Compensation?
- Uber in advanced talks to sell air taxi unit: Axios
- Sick of Roaming Fees? Now Your Carrier Is Hurting Too
- Interactive Brokers' (IBKR) October DARTs Up on Higher Trading
- U.S. Should Cut the Swiss Some Slack on Currency Manipulation
- What Kind Of Shareholders Own Mitek Systems, Inc. (NASDAQ:MITK)?
- Dollar Slumps to Multi-year Lows; EUR/USD tracks 1.20
- The Zacks Analyst Blog Highlights: Chegg, Tencent, GoDaddy, Fortinet and ServiceNow
- Were Hedge Funds Wrong About Crowding Into RealPage, Inc. (RP)?
- One Metric To Rule Them All: Ground Rents Income Fund PLC (LON:GRIO)
- Bellerophon Provides Clinical Program Update and Reports Third Quarter 2020 Financial Results
- HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Opera Limited (OPRA) Investors With Losses to Contact its Attorneys: Important Class Action Deadline Approaching
- Unibail-Rodamco-Westfield (“URW”) announces tender offer results
- Is Sirius International Insurance (SG) A Good Stock To Buy Now?
- Labrador Iron Ore Royalty Corporation Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
- GE Aviation Furloughs Half Its Engine Manufacturing Workforce Amid Coronavirus Pandemic
- RTX CLASS ACTION FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Raytheon Technologies Corporation
- Trump's coronavirus stimulus is still evolving. Here's what it should include, experts say
- Silver Price Daily Forecast – Silver Attempts To Break Through The Key Resistance Level
- Top 5 Things to Know in the Market on Monday, June 1st